Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-24-001425

Director sold 2,911 shares at an average $38.06 ($110,788)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
GIVEN DOUGLAS B Director 2024-01-11 Sale 10b5-1 −1,811 $37.76 $68,383 130,811 D
GIVEN DOUGLAS B Director 2024-01-11 Sale 10b5-1 −1,100 $38.55 $42,405 129,711 D
Open-market sales · 2,911 sh · avg $38.06 · $110,788
Loading xslF345X05/wk-form4_1705446400.xml…